FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Levetiracetam Extended-Release Oral Tablets, USP
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Lotus Pharmaceutical Co. Ltd. (New 09/03/2019)

Company Contact Information:
866-770-3024

Presentation Posting Date Related Information
Levetiracetam (Roweepra XR) Extended-Release Tablets, 750 mg 60 ct. bottle; (NDC 69102-201-60) 09/03/2019 The discontinuation of this product is a business decision.
Levetiracetam (Roweepra XR) Extended-Release Tablets, 500 mg 60 ct. bottle; (NDC 69102-200-60) 09/03/2019 The discontinuation of this product is a business decision.

Teva Pharmaceuticals (New 06/07/2019)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
500mg (NDC 0591-3635-60) 06/07/2019 This was a business-related decision to discontinue manufacturing these products.
750mg (NDC 0591-3699-60) 06/07/2019 This was a business-related decision to discontinue manufacturing these products.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English